Back
InMed Pharmaceuticals Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
27
INM
InMed Pharmaceuticals
Last Price:
0.24
Seasonality Move:
23.96%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INM is experiencing selling pressure, which indicates risk of future bearish movement.
InMed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.29 | Sell |
| 20-day SMA: | 0.26 | Sell |
| 50-day SMA: | 0.27 | Sell |
| 200-day SMA: | 0.29 | Sell |
| 8-day EMA: | 0.27 | Sell |
| 20-day EMA: | 0.27 | Sell |
| 50-day EMA: | 0.26 | Sell |
| 200-day EMA: | 0.45 | Sell |
InMed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 45.36 | Sell |
| Chaikin Money Flow: | -183468 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
InMed Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for InMed Pharmaceuticals Stock
Is InMed Pharmaceuticals Stock a Buy?
- InMed Pharmaceuticals share price is 0.24 while INM 8-day simple moving average is 0.29, which is a Sell signal.
- The stock price of INM is 0.24 while InMed Pharmaceuticals 20-day SMA is 0.26, which makes it a Sell.
- InMed Pharmaceuticals 50-day simple moving average is 0.27 while INM share price is 0.24, making it a Sell technically.
- INM stock price is 0.24 and InMed Pharmaceuticals 200-day simple moving average is 0.29, creating a Sell signal.
INM Technical Analysis vs Fundamental Analysis
Sell
27
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy or a Sell?
-
InMed Pharmaceuticals stock is rated a Sell
The current InMed Pharmaceuticals [INM] share price is $0.24. The Score for INM is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
InMed Pharmaceuticals Stock Info
Market Cap:
3.24M
Price in USD:
0.24
Share Volume:
317.63K
InMed Pharmaceuticals 52-Week Range
52-Week High:
0.78
52-Week Low:
0.12
Sell
27
InMed Pharmaceuticals (INM)
is a Sell
InMed Pharmaceuticals Share Price Forecast
-
What is the InMed Pharmaceuticals stock price today?
The InMed Pharmaceuticals stock price is 0.24 USD today. -
Will INM stock go up or go down?
InMed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is InMed Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, InMed Pharmaceuticals is overvalued.
Is InMed Pharmaceuticals Stock a Buy?
- InMed Pharmaceuticals share price is 0.24 while INM 8-day exponential moving average is 0.27, which is a Sell signal.
- The stock price of INM is 0.24 while InMed Pharmaceuticals 20-day EMA is 0.27, which makes it a Sell.
- InMed Pharmaceuticals 50-day exponential moving average is 0.26 while INM share price is 0.24, making it a Sell technically.
- INM stock price is 0.24 and InMed Pharmaceuticals 200-day simple moving average is 0.45, creating a Sell signal.
Technical Analysis of InMed Pharmaceuticals
Should I short InMed Pharmaceuticals stock?
- INM Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting InMed Pharmaceuticals is a Buy
- InMed Pharmaceuticals Relative Strength Index (RSI) is 45.36, which suggest InMed Pharmaceuticals is oversold
- The Bollinger Bands (25) for InMed Pharmaceuticals is ( - ), which suggest InMed Pharmaceuticals is a Buy
- The Bollinger Bands (100) for InMed Pharmaceuticals is ( - ), which suggest InMed Pharmaceuticals is a Buy
* InMed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.